Dongwha Pharm.Co.,Ltd (000020.KS)
KRW 6360.0
(-1.7%)
KRW 6360.0
(-1.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 361.1 Billion | 340.42 Billion | 293.01 Billion | 272.07 Billion | 307.15 Billion | 306.6 Billion |
| Cost of Revenue | 176.98 Billion | 159.43 Billion | 143.67 Billion | 133.4 Billion | 185.41 Billion | 190.69 Billion |
| Gross Profit | 184.12 Billion | 180.99 Billion | 149.34 Billion | 138.66 Billion | 121.73 Billion | 115.9 Billion |
| Operating Expenses | 165.11 Billion | 151.07 Billion | 126.84 Billion | 115.5 Billion | 111.81 Billion | 104.67 Billion |
| Selling, General and Administrative Expenses | 143.56 Billion | 76.62 Billion | 56.41 Billion | 50.82 Billion | 49.45 Billion | 48.27 Billion |
| Research and Development Expenses | 21.54 Billion | 19.28 Billion | 17.33 Billion | 16.91 Billion | 16.26 Billion | 15.6 Billion |
| Other Expenses | - | 55.16 Billion | 53.09 Billion | 47.77 Billion | 46.09 Billion | 400.75 Million |
| Cost and Expenses | 335.8 Billion | 310.51 Billion | 270.51 Billion | 248.91 Billion | 297.23 Billion | 295.37 Billion |
| Operating Income | 25.3 Billion | 29.91 Billion | 22.49 Billion | 23.15 Billion | 17.09 Billion | 11.22 Billion |
| Interest Expense | 308.01 Million | 370 Million | 383.11 Million | 292.15 Million | 206.95 Million | - |
| Income Tax Expense | 8.71 Billion | 1.49 Billion | 6.94 Billion | 4.92 Billion | 7.21 Billion | 4.47 Billion |
| Earnings before Tax | 36.95 Billion | 23.08 Billion | 26.52 Billion | 33.63 Billion | 16.6 Billion | 14.53 Billion |
| Net Income | 27.43 Billion | 20.38 Billion | 17.87 Billion | 28.5 Billion | 9.4 Billion | 10.06 Billion |
| Earnings Per Share Basic | 991.07 | 736.42 | 646.68 | 1032.60 | 330.20 | 365.00 |
| Earnings Per Share Diluted | 991.07 | 736.42 | 646.68 | 1032.51 | 330.20 | 365.00 |
| Weighted Average Shares Outstanding | 27.68 Million | 27.67 Million | 27.63 Million | 27.6 Million | 27.6 Million | 27.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.68 Million | 27.67 Million | 27.63 Million | 27.62 Million | 27.6 Million | 27.58 Million |
| Gross Margin | 0.51 | 0.53 | 0.51 | 0.51 | 0.40 | 0.38 |
| EBIT Margin | 0.09 | 0.13 | 0.13 | 0.13 | 0.09 | 0.07 |
| Profit Margin | 0.08 | 0.06 | 0.06 | 0.10 | 0.03 | 0.03 |
| EBITDA | 32.56 Billion | 38.23 Billion | 39.41 Billion | 44.75 Billion | 28.34 Billion | 25.89 Billion |
| Earnings Before Tax Margin | 0.07 | 0.09 | 0.08 | 0.09 | 0.06 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 115.16 Billion | 118.88 Billion | 84.24 Billion | 361.1 Billion | 87.45 Billion | 89.99 Billion |
| Cost of Revenue | 63.42 Billion | 66.06 Billion | 39.19 Billion | 176.98 Billion | 42.43 Billion | 43.81 Billion |
| Gross Profit | 51.73 Billion | 52.82 Billion | 45.04 Billion | 184.12 Billion | 45.02 Billion | 46.17 Billion |
| Operating Expenses | 47.13 Billion | 46.34 Billion | 85.8 Billion | 342.33 Billion | -42.33 Billion | -40.71 Billion |
| Selling, General and Administrative Expenses | 40.97 Billion | 41.15 Billion | 40.93 Billion | - | 42.33 Billion | 40.71 Billion |
| Research and Development Expenses | 5.39 Billion | 4.65 Billion | 5.19 Billion | - | 1.19 Billion | 5.49 Billion |
| Other Expenses | -767.29 Million | -536.87 Million | -85.8 Billion | -342.33 Billion | -84.66 Billion | -81.42 Billion |
| Cost and Expenses | 110.56 Billion | 112.4 Billion | 85.8 Billion | 342.33 Billion | 42.43 Billion | 43.81 Billion |
| Operating Income | 4.59 Billion | 6.48 Billion | -1.56 Billion | 18.77 Billion | 2.69 Billion | 5.46 Billion |
| Interest Expense | 419.58 Million | 464.09 Million | 81.64 Million | 308.01 Million | 74.44 Million | 78.12 Million |
| Income Tax Expense | 1.92 Billion | 1.7 Billion | -459.13 Million | 8.71 Billion | 2.57 Billion | 2.58 Billion |
| Earnings before Tax | 5.04 Billion | 4.84 Billion | 1.1 Billion | 36.95 Billion | 8.73 Billion | 10.16 Billion |
| Net Income | 3.52 Billion | 2.98 Billion | 1.46 Billion | 27.43 Billion | 5.92 Billion | 7.5 Billion |
| Earnings Per Share Basic | 127.09 | 107.80 | 53.02 | - | 213.96 | 271.26 |
| Earnings Per Share Diluted | 127.09 | 107.80 | 53.02 | - | 213.96 | 271.26 |
| Weighted Average Shares Outstanding | 27.71 Million | 27.71 Million | 27.71 Million | 27.68 Million | 27.67 Million | 27.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.71 Million | 27.71 Million | 27.71 Million | 27.68 Million | 27.67 Million | 27.67 Million |
| Gross Margin | 0.45 | 0.44 | 0.53 | 0.51 | 0.51 | 0.51 |
| EBIT Margin | 0.08 | 0.09 | -0.02 | - | 0.51 | 0.51 |
| Profit Margin | 0.03 | 0.03 | 0.02 | 0.08 | 0.07 | 0.08 |
| EBITDA | 9.27 Billion | 10.68 Billion | -1.56 Billion | - | 45.02 Billion | 46.17 Billion |
| Earnings Before Tax Margin | 0.04 | 0.05 | -0.02 | 0.05 | 0.03 | 0.06 |
RAJSREESUG
SILINV
SMPEF
ALTD
FWZ
CC